We demonstrated that NRF2, whose high expression correlates with tumor aggressiveness and poor prognosis, induced RhoA expression by its binding to and silence ERR1 gene and promoted breast cancer cell proliferation and metastasis. This evidence concerns the gene NFE2L2 and breast cancer.